Dr. Singhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Department Of Neurology, Bwh
Boston, MA 02115Phone+1 617-732-5500Fax+1 203-688-5599
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2009 - 2012
Yale-New Haven Medical CenterInternship, Internal Medicine, 2008 - 2009
All India Institute of Medical SciencesClass of 2002
Certifications & Licensure
OH State Medical License Current
MA State Medical License 2011 - 2025- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Microglial Activation Positron Emission Tomography (PET) Brain Imaging in Multiple Sclerosis and Alzheimer's Disease Start of enrollment: 2016 May 02
- Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA Start of enrollment: 2017 Mar 24
- Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis Start of enrollment: 2019 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsClinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping.Alain Ndayisaba, Ariana T Pitaro, Andrew S Willett, Kristie A Jones, Claudio Melo de Gusmao
Cerebellum. 2024-02-01 - 14 citationsHumoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.Kathryn B Holroyd, Brian C Healy, Sarah Conway, Maria Houtchens, Rohit Bakshi
Multiple Sclerosis and Related Disorders. 2022-11-01 - 157 citations11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.Tarun Singhal, Tanjore K. Narayanan, Viney Jain, Jogeshwar Mukherjee, Joseph Mantil
Molecular Imaging and Biology. 2008-01-01
Press Mentions
Tiziana Announces Positive Clinical Data from a Secondary Progressive Multiple Sclerosis Patient Treated for Six Months with Intranasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal AntibodyMarch 10th, 2022- Researchers Pursue 'Hidden Pathology' to Explain Fatigue in Multiple SclerosisAugust 26th, 2020
PET Tracer Can Help ID Early Signs of MS ProgressionJuly 10th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
